Vascular Biogenics Ltd (VBLT)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -36.994 | -17.949 | -32.379 | -35.603 | -53.638 | -56.258 | -68.499 | -45.789 |
| Return on Equity (%) | -41.345 | -20.627 | -37.54 | -43.757 | -72.577 | -73.426 | -88.467 | -59.971 |
| Return on Invested Capital (%) | -42.232 | -21.704 | -38.808 | -45.215 | -75.339 | -73.901 | -89.637 | -82.81 |
| Operating Margin (%) | N/A | -72.93 | -3476.239 | -3406.406 | -2616.052 | -3890.104 | -4896.505 | -3633.548 |
| Net Profit Margin (%) | N/A | -73.125 | -3497.094 | -3462.1 | -2627.44 | -3895.833 | -4909.422 | -3633.548 |
| Book Value Per Share | 1.576 | 1.871 | 1.48 | 0.999 | 0.642 | 0.759 | 0.322 | 1.679 |
| Earnings Per Share | -0.595 | -0.339 | -0.57 | -0.542 | -0.503 | -0.435 | -0.463 | -1.251 |
| Cash Per Share | 0.431 | 0.224 | 0.818 | 0.263 | 0.274 | 0.32 | 0.253 | 1.314 |
| Working Capital Per Share | 1.553 | 1.703 | 1.308 | 0.81 | 0.509 | 0.654 | 0.221 | 1.415 |
| Operating Profit Per Share | N/A | 0.453 | 0.01 | 0.012 | 0.011 | 0.006 | 0.008 | 0.013 |
| EBIT Per Share | -0.595 | -0.339 | -0.57 | -0.542 | -0.503 | -0.435 | -0.463 | -1.251 |
| EBITDA Per Share | -0.595 | -0.339 | -0.57 | -0.542 | -0.503 | -0.435 | -0.463 | -1.251 |
| Free Cash Flow Per Share | -0.581 | -0.128 | -0.54 | -0.588 | -0.526 | -0.432 | -0.467 | -1.273 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 26.9M | 29.88M | 35.88M | 35.88M | 48.19M | 68.71M | 69.75M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 69.35M | 69.75M | 69.75M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -376600 |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -376600 |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.4M |
| Price to Earnings Ratio | -0.2 |
| Price to Sales Ratio | 7.27 |
| Price to Cash Ratio | 0.19 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | - |
| Shares Outstanding | 9M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
